Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Purple Biotech Ltd. American Depositary Shares (PPBT)

https://www.purple-biotech.com

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/20/2015

Market Cap

12,370,824

Shares Outstanding

247,050,000

Weighted SO

24,705,374

Total Employees

N/A

Upcoming Earnings

05/01/2017

Similar Tickers

PLUR --.--%

BLRX --.--%

ARDS --.--%

ENLV --.--%

ANEB --.--%

PMVP --.--%

MIRO --.--%

ZIVO --.--%

BNOX --.--%

Beta

0.3870

Last Div

0.0000

Range

0.302-1.8

Chg

-0.0009

Avg Vol

311693

Mkt Cap

12370824

Exch

NASDAQ

Country

IL

Phone

972 3 933 3121

DCF Diff

-0.2049

DCF

0.5743

Div Yield

0.0000

P/S

0.0000

EV Multiple

-0.1308

P/FV

0.3086

Div Yield %

0.0000

P/E

-0.5101

PEG

-0.0180

Payout

0.0000

Current Ratio

1.3398

Quick Ratio

1.3398

Cash Ratio

1.1733

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

6377.4121

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.5054

ROA

-0.4707

ROE

-0.5126

ROCE

-0.3618

NI/EBT

0.9952

EBT/EBIT

1.6620

EBIT/Rev

0.0000

Debt Ratio

0.0077

D/E

0.0099

LT Debt/Cap

0.0039

Total Debt/Cap

0.0098

Int Coverage

-5.2694

CF/Debt

-61.1173

Equity Multi

1.2851

Rec Turnover

0.0000

Pay Turnover

0.0572

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-0.7233

FCF/Share

-0.7233

Cash/Share

0.4184

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

-61.1173

ST Coverage

-100.8763

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

0.3086

P/B

0.3086

P/S

0.0000

P/E

-0.5101

P/FCF

-0.6593

P/OCF

-0.5101

P/CF

-0.5101

PEG

-0.0180

P/S

0.0000

EV Multiple

-0.1308

P/FV

0.3086

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 14, 06:50 Purple Biotech Completes Patient Enrollment in Phase 2 Pancreatic Cancer Trial GlobeNewswire Inc. Nov 21, 06:50 Purple Biotech Reports Third Quarter 2023 Financial Results

Revenue Product Segmentation